Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 1
2007 1
2008 1
2009 1
2015 1
2018 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients.
Cáceres-Lóriga FM, Pérez-López H, Morlans-Hernández K, Facundo-Sánchez H, Santos-Gracia J, Valiente-Mustelier J, Rodiles-Aldana F, Marrero-Mirayaga MA, Betancourt BY, López-Saura P. Cáceres-Lóriga FM, et al. Among authors: betancourt by. J Thromb Thrombolysis. 2006 Apr;21(2):185-90. doi: 10.1007/s11239-006-4969-y. J Thromb Thrombolysis. 2006. PMID: 16622616 Review.
Recombinant streptokinase: evidences from clinical use.
Llerena LD, Cáceres-Lóriga FM, Betancourt BY. Llerena LD, et al. Among authors: betancourt by. Eur Heart J. 2005 Jul;26(14):1448-9; author reply 1449-50. doi: 10.1093/eurheartj/ehi319. Epub 2005 May 19. Eur Heart J. 2005. PMID: 15905301 No abstract available.
Intralesional injections of Citoprot-P (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation.
Fernández-Montequín JI, Infante-Cristiá E, Valenzuela-Silva C, Franco-Pérez N, Savigne-Gutierrez W, Artaza-Sanz H, Morejón-Vega L, González-Benavides C, Eliseo-Musenden O, García-Iglesias E, Berlanga-Acosta J, Silva-Rodríguez R, Betancourt BY, López-Saura PA; Cuban Citoprot-P Study Group. Fernández-Montequín JI, et al. Among authors: betancourt by. Int Wound J. 2007 Dec;4(4):333-43. doi: 10.1111/j.1742-481X.2007.00344.x. Epub 2007 Oct 22. Int Wound J. 2007. PMID: 17953679 Free PMC article. Clinical Trial.
Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.
Fernández-Montequín JI, Betancourt BY, Leyva-Gonzalez G, Mola EL, Galán-Naranjo K, Ramírez-Navas M, Bermúdez-Rojas S, Rosales F, García-Iglesias E, Berlanga-Acosta J, Silva-Rodriguez R, Garcia-Siverio M, Martinez LH. Fernández-Montequín JI, et al. Among authors: betancourt by. Int Wound J. 2009 Feb;6(1):67-72. doi: 10.1111/j.1742-481X.2008.00561.x. Int Wound J. 2009. PMID: 19291119 Free PMC article. Clinical Trial.
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction.
Betancourt BY, Marrero-Miragaya MA, Jiménez-López G, Valenzuela-Silva C, García-Iglesias E, Hernández-Bernal F, Debesa-García F, González-López T, Alvarez-Falcón L, López-Saura PA; Cuban National Network of Pharmacoepidemiology. Betancourt BY, et al. BMC Clin Pharmacol. 2005 Nov 2;5:5. doi: 10.1186/1472-6904-5-5. BMC Clin Pharmacol. 2005. PMID: 16262910 Free PMC article.
11 results